Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
about
Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic originCurrent status of transarterial radioembolizationArterial Therapies of Non-Colorectal Liver MetastasesSide effects of yttrium-90 radioembolizationManagement of patients with hepatic metastases from neuroendocrine tumorsNeuroendocrine pancreatic tumors: guidelines for management and updateNew therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.Radioembolization of hepatic tumorsWell-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapiesInterventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.New treatment options for patients with advanced neuroendocrine tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management.Update on pancreatic neuroendocrine tumors.Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionTreatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.Research reporting standards for radioembolization of hepatic malignancies.Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Radioembolization for primary and metastatic liver cancer.Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Radioembolization in the treatment of neuroendocrine tumor metastases to the liver.Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy.Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)A multimodal approach to the management of neuroendocrine tumour liver metastasesRadioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesPhase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyMetastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Pancreatic Neuroendocrine Tumors: an Update.Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesThe joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
P2860
Q21296729-9BE72901-FFE0-408F-935D-B994A2D904B9Q26744307-662EA788-BD06-4CCE-8B26-AEEE82CCA452Q26764990-B58C1B16-3353-42F9-A13E-DFFD75C9287BQ26821887-7562DA7D-8EFB-4579-80A2-BBA859C916A2Q27008832-5BB2C3A9-E12B-4B67-9440-D413F5C478B4Q28256132-C1CB95E0-A374-4E3D-AC0F-E048C1FC8688Q30364864-67DE9B94-6600-4CF0-A4B7-4B2FD07E8720Q33782024-BD188A64-49C3-4D0E-BB29-9FD7329436F3Q33820777-6FFA827F-F9E5-49EC-B4BC-B8D983394CCDQ33840177-5005C65F-79DC-41F0-A6EF-38B0C3894FE3Q33851393-B87E5615-CB61-4349-84AD-B20D3FF9F5B7Q33894587-CFC101D7-0940-4233-8C42-82C69D398ACAQ34173336-1BFB1C65-6042-4322-BBC2-B0C2344B46F4Q34248487-7D61AF2A-8296-4A7E-85C3-E80AD1AC36E1Q34301030-E52CE91B-13A1-4389-A271-A77E6B0AFC3AQ34389590-704A7FF2-AA19-4191-ACA1-EDFEFAAA5DC8Q34453043-21D5B3C9-22C3-47AF-B260-0F4700794336Q34702065-FBCD3F8A-04C7-4283-AD5E-EB2885BDCE64Q34743520-6053FEC2-FFD2-41C4-8D23-839391C10410Q35018379-2F367101-0095-449A-86BB-3B23980BFAAAQ35046078-BEC017AD-A6D5-4C12-B596-EE853AD951F0Q35111887-2B5728C6-B804-424E-8E8D-E81C5C2181E3Q35371197-23FD1171-3EAA-4F4E-B97F-1FEEC2BE1F31Q35564038-3BAEB451-EFBE-4544-8837-A1BB36C4946AQ35584891-DEF05CFC-293C-4098-96E3-D3CD0CF14DF8Q35658025-3516B356-8DFB-4DAB-A9AE-12DAFD88E7E8Q35659906-9935CEDF-BA5A-4A33-A898-F22B20A2B0A5Q35675390-F6CC29E7-70F0-4465-8BF2-80C4C5E1D032Q35721324-4C64735B-D806-47C5-8B57-E245A107AF27Q35760798-80049417-5C10-4AE2-8C5C-5350BA1DA072Q35810562-2B474C71-0982-4D25-903E-E7179E3F990CQ35815482-99A0F528-EAE6-483E-978E-F71A2A936180Q35822196-992271ED-75CF-4034-95CC-66B5BBE9D5DEQ35934322-82D5346A-0C6E-4D46-92D3-6DD6BD08AA29Q36194191-21AD9E47-F1A4-4949-BC63-641E443113B6Q36392298-8310B079-00E5-40F8-9ACD-BDB8B9E54000Q36400062-F72FC902-165D-472D-955D-7973F8F8956EQ36512778-67E2D057-E25B-43F2-B6F6-D56E7E7FB176Q36656612-19A65B00-5C94-4C4C-AF58-6A1787E6DEB2Q36755905-6E084071-3562-46AC-AC58-3CD8C60258F6
P2860
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radioembolization for unresect ...... early results in 148 patients.
@en
Radioembolization for unresect ...... early results in 148 patients.
@nl
type
label
Radioembolization for unresect ...... early results in 148 patients.
@en
Radioembolization for unresect ...... early results in 148 patients.
@nl
prefLabel
Radioembolization for unresect ...... early results in 148 patients.
@en
Radioembolization for unresect ...... early results in 148 patients.
@nl
P2093
P1476
Radioembolization for unresect ...... early results in 148 patients
@en
P2093
Andrew S Kennedy
Bonita Jones
Carroll Overton
Charles Nutting
Dennis Carter
Doug Coldwell
Holger Palmedo
Patrick McNeillie
Ravi Murthy
P304
P356
10.1097/COC.0B013E31815E4557
P50
P577
2008-06-01T00:00:00Z